Understanding PGx Testing

Learn from the AttoPGx blog

How Pharmacogenomics is Revolutionising Autoimmune Disease Treatment

Published 12/12/2024

Pharmacogenomics has emerged as a key component in managing autoimmune diseases, including rheumatoid arthritis (RA), where the immune system attacks its own tissues. These conditions often require complex, long-term treatments. By tailoring drug therapies based on individual genetic profiles, pharmacogenomic testing offers a way to improve patient outcomes while minimising adverse effects.

The Evolution of PGx Testing: From HIV to Mental Health

Published 10/12/2024

Pharmacogenetics (PGx) is transforming the way we approach medicine. This innovative field explores how our genetic makeup influences the way we respond to medications, enabling more personalised treatments. PGx testing has been gaining traction over the past few decades, but where did it all begin, and how has it evolved into the precision tool it is today?

Testing for ADHD In Children

Published 05/12/2024

Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder affecting millions of children worldwide. While medications are often prescribed to help manage ADHD symptoms, the response to these medications can vary significantly among individuals. This variability is where pharmacogenomic (PGx) testing comes into play, offering a powerful tool for personalised medicine that takes genetics into account.